Company profile · free preview

First Tracks Biotherapeutics Inc

TRAX · NASDAQ · Healthcare · Updated 11/13/2026

Five-year financials

Fiscal year
Revenue
Net income
Diluted EPS
Operating cash flow
Free cash flow
Cash
Total debt

Financials are being prepared.

Want the story behind these numbers? Ask Osiris anything about First Tracks Biotherapeutics Inc's filings — free.

Create free account

First Tracks Biotherapeutics Inc return on capital (fiscal 2024)

ROIC

—

Return on capital

—

Return on equity

-40.9%

Return on assets

-37.0%

Gross margin

—

Operating margin

—

Net debt / EBITDA

0.69x

First Tracks Biotherapeutics Inc insider buying and selling

Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.

DateInsiderTypeSharesPrice
2026-09-02Ware J. AnthonySale39,265$44.78

SEC filings

Ask anything about First Tracks Biotherapeutics Inc's filings

"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.

Start researching free

Compare TRAX head-to-head

More Healthcare companies